OCTaVIA 2.0.2

OCTaVIA is a cutting-edge diagnostic technology that combines optical coherence tomography with artificial intelligence algorithms to provide detailed and accurate assessments of eye health.

OCTaVIA uses light waves to create high-resolution cross-sectional images of the retina, optic nerve, and other structures in the eye. These images are then analyzed by AI algorithms to detect and track various eye conditions.

OCTaVIA can help detect conditions such as glaucoma, macular degeneration, diabetic retinopathy, and other retinal diseases at their early stages, allowing for timely intervention and treatment.

Yes, OCTaVIA is a non-invasive and safe diagnostic tool that does not expose patients to any harmful radiation. It is commonly used in optometry clinics and ophthalmology practices.

An OCTaVIA scan usually takes a few minutes per eye. The process is quick and comfortable for patients, requiring them to sit still and focus on a target during the scan.

Yes, OCTaVIA is valuable for monitoring the progression of various eye conditions over time. By comparing sequential scans, eye care professionals can assess changes and adjust treatment plans accordingly.

Coverage for OCTaVIA may vary depending on the insurance provider and the specific medical indication for the scan. Patients are advised to check with their insurance company regarding coverage details.

No special preparations are typically required before an OCTaVIA scan. Patients may be advised to remove contact lenses if applicable and inform their eye care provider about any medications they are taking.

OCTaVIA scans are generally safe for most individuals, including children and seniors. However, patients with certain medical conditions or eye implants may not be suitable candidates. It is best to consult with an eye care professional.

While specific FDA approval status may vary by region or country, OCTaVIA technology used by The New England College of Optometry adheres to regulatory standards for medical devices and diagnostic tools.